Submission of Abstracts

*Submissions are strictly by invitation only.

Submission Period

December 10 (Tuesday), 2024

January 31 (Friday), 2025
February 14 (Friday), 2025

Abstract Submission Guidelines

  • Abstracts must be submitted exclusively via this website. Submissions via email or other methods will not be accepted.
  • Abstracts will be evaluated by the Scientific Committee.
  • Accepted abstracts will be published and distributed at the Conference.
  • All submitted abstracts must be original.
  • All participants are required to present oral presentations.
  • The duration of each presentation will be determined by the review board.
  • Abstracts must be submitted by the specified deadline.

Abstract Preparation Guidelines

  • The abstract title should be in all uppercase letters and succinctly convey the nature of the investigation.
  • Degrees, titles, and appointments of authors should be omitted. The first author listed will be the designated presenter at the Conference.
  • Please indicate the city and country where the study originated.
  • Presentation style: Oral presentations only
    All participants are required to give an oral presentation. The review board will allocate presentation times.
  • Organize the body of the abstract as follows:

    a. A brief statement of the purpose of the study

    b. A description of the methods used

    c. A summary of the results, presented in sufficient detail to support the conclusions

    d. The conclusions reached (It is not acceptable to state, "The results will be discussed.")

  • Use standard abbreviations; define any unusual abbreviations in parentheses after their first occurrence. Minimize the use of abbreviations.
  • Use non-proprietary (generic) names for drugs.
  • Keep your abstract concise—limit it to 300 words.
  • Caution! Some characters (', ", -, etc.) may not be accepted when copied from a Word file, and you may receive an error message. For these characters, please type them directly in the Abstract Submission Form.
    Additionally, for special characters such as ≥ and ±, please replace them with the correct HTML tags listed here: Special Characters List.
  • Click the "Abstract Submission" button at the bottom of this page for further instructions.
  • For technical difficulties, please contact the Conference Secretariat at: icbtrt2025@convex.co.jp.

Abstracts will be accepted in the following categories

1. Basic Science / Molecular Biology / Target Discovery
2. Molecular Pathology / Classification / Biomarkers
3. Genomics / Epigenetics / Bioinformatics
4. Cancer Neuroscience
5. Clinical Trials: Immunologic
6. Clinical Trials: Targeted Therapy
7. Clinical Trials: Other Therapy
8. Viral and Gene Therapy
9. Pediatric Neuro-Oncology
10. Genetic CNS Tumor Syndrome
11. Neuroimaging
12. Neurosurgery
13. Radiation Oncology
14. Drug Delivery
15. Preclinical Experimental Therapeutics / Tumor Models
16. Quality of Life / Survivorship
17. Epidemiology / Health Disparities / Social Determinants of Health
18. Others

Online Submission

*If you need to review or modify your existing abstract, please click the 'Abstract Submission' button and log in with your ID and password.

PAGE TOP